Alliances in U.S. and Europe biotech companies by focus 2019
During 2019, pure biotech alliances in the U.S. and Europe had a potential deal volume of over 52 billion U.S. dollars. Thus, biotech-biotech alliances had for the first time a larger volume than mixed biotech-pharma alliances. This statistic depicts alliances involving biotech companies in the United States and Europe, sorted by pure-play biotech or mixed type.
